
‘With Breast Cancer Awareness Month (BCAM) less than two weeks away, the latest bombshell GMO/Roundup study produced by a French research team, and presently making international headlines, is well-timed. The researchers found, in the first long-term GM corn and Roundup feeding study of its kind, that female rats, exposed to concentrations well below official safety limits, developed massive, progressive mammary tumors which either lead to premature death, or required euthanasia due to their great suffering.
Why would this be of concern to BCAM? After all, BCAM is the annual pinkwashing celebration, where people collectively and forcibly remove the thought of there being preventable and treatable causes of breast cancer from their minds, hurl themselves over the lemming-like cliff of cause-marketing, e.g. Buckets for a Cure, sacrificing their time, energy and money raising billions more for a pharmaceutical cure for a pharmaceutically incurable condition. This annual ritual celebrates ribbon-wearing vacuity, pretending like “carcinogens” don’t exist, or that it doesn’t matter that a carcinogen-producing chemical company, now defunct Imperial Chemical Industries, and its pharmaceutical subsidiary, Zeneca, co-founded Breast Cancer Awareness Month in 1985.
Zeneca, of course, merged with Astra AB in 1999, becoming AstraZeneca, manufacturer of the breast cancer blockbuster drugs Arimidex and Tamoxifen. By pushing for widespread adoption of breast screenings they generated millions of new and future customers (mammography-induced breast cancer), even while one of the main forms of mammography-detected cancer, Ductal Carcinoma In Situ (DCIS), is often intrinisically benign, better left untreated with conventional, highly toxic “therapies” like radiation and chemotherapy.
The conflict of interest here is as devastating as it is obvious, which is why we hope the new finding linking GM corn and Roundup herbicide to breast cancer will compel BCAM to respond, and change their awareness strategy to become more patient- versus industry-friendly. One thing is for sure. The study’s findings were not vague or equivocal, but disturbingly clear…’